EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological Predictors of Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer

Mousumi Marjiara Begum, Anwarul Haque

Islami Bank Medical College Journal · 31.07.2024 · 19 (2) · 43-53

DOI: 10.70945/ibmcj.v19i02.0212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Islami Bank Medical College Journal, online erschienen am 31.07.2024. Verfasst von Mousumi Marjiara Begum und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) predicts long-term survival in breast cancer, yet population-specific predictors remain poorly characterised in South Asian, resource-limited oncology settings.

Objective

This study aimed to determine the pCR rate and identify independent clinicopathological predictors of pCR among women receiving NACT for breast cancer at a Bangladeshi tertiary oncology centre.

Methods

This retrospective cohort study enrolled 110 consecutive women with stage II–III breast cancer receiving NACT at the Department of Oncology, Rajshahi Medical College Hospital, between June and December 2022. Variables were compared between pCR and non-pCR groups using chi-square and t-tests, with independent predictors estimated via multivariable logistic regression using SPSS version 26.0. Results: pCR (ypT0/is ypN0) occurred in 34/110 patients (30.9%). Mean age was 41.2±14.8 years, mean tumour size 5.7±1.9 cm, and mean Ki-67 index 50.3±23.1%. pCR rates were numerically highest in triple-negative tumours (41.7%) versus luminal B disease (24.0%, p=0.570) and stage IIA (37.0%) versus stage IIIB disease (20.7%, p=0.533). Breast-conserving surgery occurred in 56.4% overall, lower among patients achieving pCR (41.2% vs 63.2%, p=0.052). Complications occurred in 6.4%. On multivariable analysis, no variable independently predicted pCR: grade 3 (adjusted OR 1.46, 95% CI 0.60–3.55, p=0.405), nodal stage (aOR 1.18, p=0.533), and tumour size (aOR 1.09, p=0.468) showed the strongest, non-significant, point estimates. Conclusion: pCR was achieved in nearly one-third of patients; routinely available clinicopathological variables showed directionally coherent but statistically non-significant associations, supporting larger multicentre regional studies.

Zitieren

APA

Begum, M. M., & Haque, A. (2024). Clinicopathological Predictors of Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer. Islami Bank Medical College Journal, 19(2), 43-53. https://doi.org/10.70945/ibmcj.v19i02.0212

Vancouver

Begum MM, Haque A. Clinicopathological Predictors of Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer. Islami Bank Medical College Journal. 2024;19(2):43-53. doi:10.70945/ibmcj.v19i02.0212

BibTeX
@article{Begum2024,
  author = {Begum, Mousumi Marjiara and Haque, Anwarul},
  title = {Clinicopathological Predictors of Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer},
  journal = {Islami Bank Medical College Journal},
  year = {2024},
  volume = {19},
  number = {2},
  pages = {43--53},
  doi = {10.70945/ibmcj.v19i02.0212}
}
Kostenlos starten →